Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

To see all exchange delays, please see disclaimer. Google recommends using Chrome.

Recent Quotes 30 days You have no recent quotes. Add CVM to my calendars. Q3 CEL-SCI Corp Earnings Release Estimated - 4: Q1 Mar '17 Net profit margin Analyst Estimates - MarketWatch.

CVM Stock Price - CEL-SCI Corp. Stock Quote (U.S.: NYSE MKT) - MarketWatch

SEC Filings - EDGAR Online. Major Holders - MSN Money.

Research Reports - Reuters. Settings Technicals Link to this view.

Bradesco RI

Volume delayed by 15 mins. Prices are not from all markets. Most Recent Quarter Most Recent Annual.

Add or remove columns Save changes Cancel. CEL-SCI Corporation is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company is focused on activating the immune system to fight cancer and infectious diseases.

It operates through the segment of research and development of certain drugs and vaccines. It is focused on the development of Multikine Leukocyte Interleukin, Injection , an investigational immunotherapy under development for treatment of certain head and neck cancers, and anal warts or cervical dysplasia in human immunodeficiency virus and human papillomavirus co-infected patients and Ligand Epitope Antigen Presentation System L.

Chief Executive Officer, Treasurer, Director Age: Senior Vice President - Research, Cellular Immunology Age: Chief Scientific Officer Age: Esterhazy Independent Director Age: Google Finance Beta available in: Hong Kong - Canada - U.